Sign in
4

Changes in Ownership

IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-26-024765

Interim CEO & General Counsel gave up 26,755 shares (to pay taxes)

  • Interim CEO & General Counsel acquired 62,493 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Vogt Frederick G Interim CEO & General Counsel 2026-03-05 Option exercise +62,493 556,293 D
Vogt Frederick G Interim CEO & General Counsel 2026-03-05 Shares withheld for taxes −26,755 $4.58 $122,538 529,538 D
Derivatives
Vogt Frederick G Interim CEO & General Counsel 2026-03-05 Option exercise · Restricted Stock Units −62,493 125,007 D
Loading xslF345X05/tm268187-4_4seq1.xml…